Table 1.
Total | Anterior | Posterior | p valuea | |
---|---|---|---|---|
No. of individuals | 186 | 37 | 149 | |
Sex | ||||
Male | 111 (59.7%) | 20 (54.1%) | 91 (61.1%) | 0.44 |
Female | 75 (40.3%) | 17 (45.9%) | 58 (38.9%) | |
Age (years) | 50.0 ± 17.9 | 46.6 ± 17.3 | 50.9 ± 18.0 | 0.19 |
Duration of disease (months) | 12.0 ± 18.4 | 13.2 ± 21.6 | 11.7 ± 17.6 | 0.70 |
Vertebra affected | 0.80 | |||
Lumbar | 92 (49.5%) | 19 (51.4%) | 73 (49%) | |
Thoracic | 94 (50.5%) | 18 (48.6%) | 76 (51%) | |
Chemotherapy duration (days) | ||||
Preoperative | 14.0 ± 10.9 | 11.9 ± 7.7 | 14.5 ± 11.5 | 0.19 |
Postoperative | 16.5 ± 7.5 | 19.4 ± 9.7 | 15.8 ± 6.7 | 0.01 |
Vital status | ||||
Dead | 2 (1.1%) | 1 (2.7%) | 1 (0.7%) | 0.47 |
Alive | 117 (62.9%) | 22 (59.5%) | 95 (63.8%) | |
Unknown | 67 (36.0%) | 14 (37.8%) | 53 (35.5%) |
a T test used to compare continuous variables; chi-square and Fisher’s tests used to compare the categorical variables